TRIB1 and neoplasm: This contrasts with the oncogenic role of TRIB1 in MEK1/ERK signalling, suggesting TRIB2 acts as a tumour suppressor by promoting the activation of stress-activated, rather than proliferative, MAPK pathways in response to stress.